These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30188338)

  • 41. Hospitalized patients' preference in the treatment of insomnia: pharmacological versus non-pharmacological.
    Azad N; Byszewski A; Sarazin FF; McLean W; Koziarz P
    Can J Clin Pharmacol; 2003; 10(2):89-92. PubMed ID: 12879147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Continuation and discontinuation of benzodiazepine prescriptions: A cohort study based on a large claims database in Japan.
    Takeshima N; Ogawa Y; Hayasaka Y; Furukawa TA
    Psychiatry Res; 2016 Mar; 237():201-7. PubMed ID: 26805564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Social support and sleep quality in older benzodiazepine users.
    Proulx-Tremblay V; Allary A; Payette MC; Benyebdri F; Boudreau MM; Bernard C; Léveillé V; Desrosiers C; Cruz-Santiago D; Gagné MH; Bertrand JA; Grenier S
    Aging Ment Health; 2020 Sep; 24(9):1437-1443. PubMed ID: 30977682
    [No Abstract]   [Full Text] [Related]  

  • 44. Benzodiazepines and related drugs for insomnia in palliative care.
    Hirst A; Sloan R
    Cochrane Database Syst Rev; 2002; (4):CD003346. PubMed ID: 12519593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.
    Morin CM; Bastien C; Guay B; Radouco-Thomas M; Leblanc J; Vallières A
    Am J Psychiatry; 2004 Feb; 161(2):332-42. PubMed ID: 14754783
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials.
    Tampi RR; Tampi DJ
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):565-74. PubMed ID: 25551131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia.
    Montgomery SA; Herman BK; Schweizer E; Mandel FS
    Int Clin Psychopharmacol; 2009 Jul; 24(4):214-22. PubMed ID: 19542983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Examining trends in the administration of "as needed" medications to inpatients with behavioral and psychological symptoms of dementia.
    Neumann RD; Faris P; Klassen R
    Am J Alzheimers Dis Other Demen; 2015 May; 30(3):247-56. PubMed ID: 25969566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alcohol consumption among Canadians taking benzodiazepines and related drugs.
    Veldhuizen S; Wade TJ; Cairney J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):203-10. PubMed ID: 19115421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk versus risk: a review of benzodiazepine reduction in older adults.
    Paquin AM; Zimmerman K; Rudolph JL
    Expert Opin Drug Saf; 2014 Jul; 13(7):919-34. PubMed ID: 24905348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database.
    Kunz D; Bineau S; Maman K; Milea D; Toumi M
    Expert Opin Pharmacother; 2012 Jan; 13(1):9-16. PubMed ID: 22107732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High Prevalence of Inappropriate Benzodiazepine and Sedative Hypnotic Prescriptions among Hospitalized Older Adults.
    Pek EA; Remfry A; Pendrith C; Fan-Lun C; Bhatia RS; Soong C
    J Hosp Med; 2017 May; 12(5):310-316. PubMed ID: 28459898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis.
    Mugunthan K; McGuire T; Glasziou P
    Br J Gen Pract; 2011 Sep; 61(590):e573-8. PubMed ID: 22152740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.
    Nowell PD; Mazumdar S; Buysse DJ; Dew MA; Reynolds CF; Kupfer DJ
    JAMA; 1997 Dec 24-31; 278(24):2170-7. PubMed ID: 9417012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Use of Benzodiazepines and Nonbenzodiazepine Hypnotics, 1999-2014.
    Kaufmann CN; Spira AP; Depp CA; Mojtabai R
    Psychiatr Serv; 2018 Feb; 69(2):235-238. PubMed ID: 29089011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disorders.
    Berney P; Halperin D; Tango R; Daeniker-Dayer I; Schulz P
    Psychopharmacol Bull; 2008; 41(3):39-47. PubMed ID: 18779775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of zaleplon in the treatment of insomnia.
    Israel AG; Kramer JA
    Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of benzodiazepine monotherapy for major depression before and after implementation of guidelines for benzodiazepine use.
    Lai IC; Wang MT; Wu BJ; Wu HH; Lian PW
    J Clin Pharm Ther; 2011 Oct; 36(5):577-84. PubMed ID: 21062331
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns and correlates of benzodiazepine use in the French general population.
    Lagnaoui R; Depont F; Fourrier A; Abouelfath A; Bégaud B; Verdoux H; Moore N
    Eur J Clin Pharmacol; 2004 Sep; 60(7):523-9. PubMed ID: 15338086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.